The level of anxiety in pregnant women in COVID-19 pandemic: a cross-sectional study.
Eur Rev Med Pharmacol Sci
; 26(15): 5581-5586, 2022 Aug.
Article
in English
| MEDLINE | ID: covidwho-1988905
ABSTRACT
OBJECTIVE:
We aimed to determine the COVID-19 anxiety level in pregnant women who presented to an outpatient clinic during the COVID-19 pandemic. PATIENTS ANDMETHODS:
This is a descriptive cross-sectional study including 203 of 310 pregnant women who presented to the outpatient clinic of a training and research hospital of the Ministry of Health between 29 September-1 October, 2020. The level of anxiety was assessed with the COVID-19 Anxiety Inventory (CAS) using a face-to-face survey method.RESULTS:
The mean age of the patients was 28.15±5.95 years. In the study, while 6.2% of women over 30 years old was identified to have psychological problems, 0.7% of those under 30 years old had such problems. The rate of diagnosis of COVID-19 in the family/acquaintances of those with an educational level of high school or higher was 56.9%, and those who had an educational level under high school had a corresponding rate of 39.5%. The rate of COVID-19 diagnosis in the family/acquaintances of those with an educational level of high school or higher was significantly higher (p<0.05). The mean COVID-19 anxiety scale score was 0.18±0.47; COVID-19 anxiety was not observed in pregnant women.CONCLUSIONS:
This study detected no anxiety in pregnant women. Therefore, it can be said that pregnant women do not need immediate psycho-social support.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
/
Qualitative research
/
Randomized controlled trials
Limits:
Adult
/
Female
/
Humans
/
Pregnancy
/
Young adult
Language:
English
Journal:
Eur Rev Med Pharmacol Sci
Journal subject:
Pharmacology
/
Toxicology
Year:
2022
Document Type:
Article
Affiliation country:
Eurrev_202208_29430
Similar
MEDLINE
...
LILACS
LIS